Papers
1
Total Citations
76
H-Index
1
About
Dr. H. Sinnett has made significant contributions to the field of pharmacogenomics, with a primary focus on the genetic variability of drug-metabolizing enzymes. Their most cited work, "Rapid Detection of CYP1A1, CYP2D6, and NAT Variants by Multiplex Polymerase Chain Reaction and Allele-Specific Oligonucleotide Assay" (1999, 76 citations), pioneered a high-throughput method for simultaneously identifying key polymorphisms in three critical cytochrome P450 and N-acetyltransferase genes. This innovative assay streamlined the detection of genetic variants that influence individual responses to chemotherapeutic agents and other drugs, laying foundational groundwork for personalized medicine. By enabling rapid, cost-effective genotyping, Sinnett’s research has directly impacted clinical strategies for optimizing drug efficacy and minimizing adverse reactions. Their work remains a cornerstone for subsequent studies in pharmacogenetics, demonstrating a lasting influence on how genetic screening is integrated into therapeutic decision-making. Dr. Sinnett’s contributions continue to inspire researchers exploring the intersection of genetics, drug metabolism, and patient-specific treatment.
Research Focus
Key Achievements
Top Papers
- 1